Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
12/1995
12/26/1995US5478839 Cyclohexane derivatives
12/21/1995WO1995018616A3 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor
12/14/1995WO1995033763A1 Novel elastase inhibitors
12/12/1995US5475106 Agonist for cholecystokinin and gastrin receptors; nervous system, gastrointestinal disorders
12/12/1995US5474995 Phenyl heterocycles as cox-2 inhibitors
12/12/1995US5474771 Inhibits T cell activation of B cells ; binds to epitope
12/07/1995WO1995032724A1 Glial mitogenic factors, their preparation and use
12/07/1995CA2191085A1 Glial mitogenic factors, their preparation and use
11/1995
11/23/1995WO1995031543A1 Dna encoding the beta subunit of a mammalian 'maxi-k' potassium channel
11/23/1995WO1995031539A1 Neurotransmitter transporter
11/23/1995WO1995031443A1 Acid amide derivatives and process for the preparation thereof
11/23/1995WO1995031197A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/23/1995CA2190532A1 Acid amide derivatives and process for the preparation thereof
11/23/1995CA2189761A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel
11/23/1995CA2189528A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/21/1995US5468872 Nerve growth factor
11/16/1995WO1995030644A1 Amide derivatives and their therapeutic use
11/15/1995EP0682040A1 Humanized immunoglobulins and their production and use
11/15/1995CN1111907A Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
11/15/1995CN1111632A Imidazodiazepine
11/14/1995US5466675 Immunological activity of rhamnolipids
11/08/1995EP0680755A1 Method for treating inflammation, ischemia-induced cell damage and muscular dystrophy
10/1995
10/24/1995US5461146 Enzyme inhibitor protecting nerve cells from degeneration
10/19/1995WO1995027490A1 Use of serotonin antagonists (5ht3) for treating fibromyalgia
10/19/1995WO1995017904A3 Botulinum toxins for treating various disorders and associated pain
10/17/1995US5459137 Muscle relaxants, anticonvulsants, neuroprotective agents
10/12/1995WO1995026736A1 Use of biopolymers for the muscle treatment
10/11/1995EP0675888A1 Sesquiterpenes, their preparation and their use as inhibitors acting on the gaba-benzodiazepine receptor
10/03/1995US5455246 Treating neuropsychiatric disorders
09/1995
09/27/1995EP0673913A1 Calcium-alkali-citrate compounds and their use as medicaments
09/21/1995WO1995021612A3 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
09/20/1995EP0672666A2 Imidazodiazepins
09/06/1995EP0625153B1 Isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same
08/1995
08/17/1995WO1995021612A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
08/17/1995CA2182680A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
08/09/1995EP0665752A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
08/09/1995CN1106380A Cyclohexane derivatives
07/1995
07/20/1995WO1995019170A1 Application of riluzole in the treatment of mitochondrial diseases
07/18/1995US5434142 Method of treatment for muscular dystrophy
07/13/1995WO1995018616A2 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor
07/13/1995CA2180122A1 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the usethereof as antagonists for the glycine/nmda receptor
07/12/1995EP0662081A1 Ureido-acetamide derivatives, preparation thereof and drugs containing same.
07/11/1995US5432155 Conotoxins I
07/06/1995WO1995017904A2 Botulinum toxins for treating various disorders and associated pain
07/06/1995CA2682117A1 The use of the neurotoxic component of a botulinum toxin for the treatment of a facial disease, disorder or condition
07/06/1995CA2589968A1 The use of the neurotoxic component of a botulinum toxin for the treatment of pain associated with muscle activity or contracture
06/1995
06/29/1995WO1995017410A1 Heterocyclic compounds
06/29/1995CA2177851A1 Heterocyclic compounds
06/28/1995EP0659174A1 Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
06/13/1995US5424451 Process for preparing aminoalkylcarbamic esters of eseroline
06/13/1995US5424318 Treating dementia, cerebrovascular diseases
06/08/1995WO1995015327A1 N-substituted azabicycloalkane derivatives as neuroleptika asf
06/07/1995EP0656002A1 3-oxo-pyrido(1,2-a -)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a -)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders
06/01/1995WO1995014478A1 Purine compositions and methods for administration
06/01/1995CA2175828A1 Purine compositions and methods for administration
05/1995
05/23/1995US5418226 Neuromuscular blocking agent anesthetic, fast-acting
05/18/1995WO1995013277A1 6-oxo-nucleosides useful as immunosuppressants
05/18/1995CA2175897A1 6-oxo-nucleosides useful as immunosuppressants
05/11/1995WO1995012399A1 Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof
05/02/1995US5412101 Sulphorous derivatives of imidazole, and their use as medicaments and the pharmaceutical compositions containing them
04/1995
04/26/1995EP0649407A1 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
04/25/1995US5410040 Mono- and diquaternary 5-alpha-hydroxy-3,16-diaminoandrostane salts; curare-like muscle relaxant activity
04/13/1995WO1995000501A3 Phenyl heterocycles as cyclooxygenase-2 inhibitors
04/12/1995EP0647266A1 D-enzyme compositions and methods of their use
04/11/1995US5405757 Synthesis of human procollagens and collagens in recombinant DNA systems
04/06/1995WO1995009007A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin
04/06/1995WO1995009006A1 Monoglyceride/lactate ester permeation enhancer
04/06/1995CA2167526A1 Monoglyceride/lactate ester permeation enhancer
04/06/1995CA2165802A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin
04/05/1995EP0646012A1 Wound healing and treatment of fibrotic disorders
03/1995
03/23/1995WO1995007911A1 K-252a DERIVATIVES WHICH ENHANCE NEUROTROPHIN-INDUCED ACTIVITY
03/22/1995EP0644182A1 Cyclohexane derivatives useful as potassium channel openers
03/22/1995CA2131749A1 Cyclohexane derivatives
03/16/1995WO1995007078A1 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
03/16/1995CA2171440A1 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
03/15/1995EP0642516A1 Macrocyclic immunomodulators
03/07/1995US5395957 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds
02/1995
02/28/1995US5393786 Administering certain phenolic compounds
02/28/1995US5393774 Phenylethanolamines, pharmaceutical compositions containing these compounds and process for preparing them
02/15/1995EP0638082A1 Macrocyclic immunomodulators
02/08/1995EP0637586A1 2-(Piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl)benzofuran-7-ol and carbamate derivatives, their preparation and their use as acetylcholinesterase inhibitors
02/06/1995CA2129462A1 2-(piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl)benzofuran-7-ol and carbamate derivatives
02/01/1995EP0636124A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same
01/1995
01/26/1995WO1995002591A1 Tri-substituted imidazoles having multiple therapeutic properties
01/26/1995CA2167311A1 Tri-substituted imidazoles having multiple therapeutic properties
01/25/1995CN1097752A Benocycloheptenes, benzoxepines and benzothiepines
01/24/1995US5384330 Pharmaceutically active 1,2,4-triamino-benzene derivatives, processes for their preparation and pharmaceutical compositions containing them
01/19/1995WO1995001956A1 Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants
01/18/1995EP0633879A1 Enantiomeric 1-phenyl-2-(2-pyridinyl)ethylamine for the treatment of neurodegenerative disorders
01/12/1995WO1995001436A1 Conotoxins having acetylcholin receptor binding properties
01/05/1995WO1995000512A1 Positive inotropic and lusitropic pyrroloquinolinone derivatives
01/05/1995WO1995000501A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors
01/05/1995WO1995000489A1 Isoquinoline derivatives as therapeutic agents
01/05/1995CA2364039A1 Use of phenyl heterocycles in the relief or treatment of rheumatoid arthritis, osteoarthritis, fever, pain, headache or dysmenorrhea
01/05/1995CA2165823A1 Isoquinoline derivatives as therapeutic agents
01/05/1995CA2163888A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors
01/03/1995US5378723 Cholinergic agonist and blocking agents
12/1994
12/28/1994EP0630255A1 Mhc conjugates useful in ameliorating autoimmunity
12/22/1994WO1994029309A1 Spiro-substituted azacycles as neurokinin antagonists
12/22/1994WO1994028923A1 Multiple botulinum toxins for treating neuromuscular disorders and conditions
1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233